nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2D6—Niacin—atherosclerosis	0.0813	0.106	CbGbCtD
Dolasetron—CYP2C9—Rosuvastatin—atherosclerosis	0.0756	0.099	CbGbCtD
Dolasetron—CYP2C9—Simvastatin—atherosclerosis	0.0703	0.092	CbGbCtD
Dolasetron—CYP2C9—Lovastatin—atherosclerosis	0.0688	0.0901	CbGbCtD
Dolasetron—CYP2C9—Pravastatin—atherosclerosis	0.0688	0.0901	CbGbCtD
Dolasetron—CYP2D6—Simvastatin—atherosclerosis	0.0643	0.0842	CbGbCtD
Dolasetron—CYP2D6—Pravastatin—atherosclerosis	0.0629	0.0824	CbGbCtD
Dolasetron—CYP2D6—Lovastatin—atherosclerosis	0.0629	0.0824	CbGbCtD
Dolasetron—CYP3A4—Rosuvastatin—atherosclerosis	0.044	0.0576	CbGbCtD
Dolasetron—CYP3A4—Ezetimibe—atherosclerosis	0.044	0.0576	CbGbCtD
Dolasetron—CYP3A4—Simvastatin—atherosclerosis	0.0409	0.0535	CbGbCtD
Dolasetron—CYP3A4—Pravastatin—atherosclerosis	0.04	0.0524	CbGbCtD
Dolasetron—CYP3A4—Lovastatin—atherosclerosis	0.04	0.0524	CbGbCtD
Dolasetron—Urinary retention—Niacin—atherosclerosis	0.00116	0.00499	CcSEcCtD
Dolasetron—Pancreatitis—Simvastatin—atherosclerosis	0.00113	0.00484	CcSEcCtD
Dolasetron—Orthostatic hypotension—Niacin—atherosclerosis	0.00112	0.00479	CcSEcCtD
Dolasetron—Abdominal distension—Niacin—atherosclerosis	0.00106	0.00456	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00106	0.00455	CcSEcCtD
Dolasetron—Jaundice—Ezetimibe—atherosclerosis	0.00105	0.0045	CcSEcCtD
Dolasetron—Abdominal distension—Pravastatin—atherosclerosis	0.00105	0.00449	CcSEcCtD
Dolasetron—Arrhythmia—Rosuvastatin—atherosclerosis	0.00104	0.00445	CcSEcCtD
Dolasetron—Pancreatitis—Pravastatin—atherosclerosis	0.00102	0.00438	CcSEcCtD
Dolasetron—Sweating increased—Pravastatin—atherosclerosis	0.00101	0.00435	CcSEcCtD
Dolasetron—Jaundice—Simvastatin—atherosclerosis	0.001	0.00429	CcSEcCtD
Dolasetron—Flatulence—Rosuvastatin—atherosclerosis	0.000996	0.00428	CcSEcCtD
Dolasetron—Dysuria—Pravastatin—atherosclerosis	0.000972	0.00417	CcSEcCtD
Dolasetron—Oedema peripheral—Ezetimibe—atherosclerosis	0.000951	0.00408	CcSEcCtD
Dolasetron—Angioedema—Rosuvastatin—atherosclerosis	0.000924	0.00396	CcSEcCtD
Dolasetron—Jaundice—Niacin—atherosclerosis	0.000918	0.00394	CcSEcCtD
Dolasetron—Stomatitis—Niacin—atherosclerosis	0.000918	0.00394	CcSEcCtD
Dolasetron—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000914	0.00392	CcSEcCtD
Dolasetron—Flushing—Lovastatin—atherosclerosis	0.000913	0.00392	CcSEcCtD
Dolasetron—Myocardial infarction—Pravastatin—atherosclerosis	0.000909	0.0039	CcSEcCtD
Dolasetron—Jaundice—Pravastatin—atherosclerosis	0.000904	0.00388	CcSEcCtD
Dolasetron—Flushing—Ezetimibe—atherosclerosis	0.000896	0.00384	CcSEcCtD
Dolasetron—Chills—Lovastatin—atherosclerosis	0.000883	0.00379	CcSEcCtD
Dolasetron—Cough—Rosuvastatin—atherosclerosis	0.000882	0.00379	CcSEcCtD
Dolasetron—Arthralgia—Rosuvastatin—atherosclerosis	0.000861	0.00369	CcSEcCtD
Dolasetron—Myalgia—Rosuvastatin—atherosclerosis	0.000861	0.00369	CcSEcCtD
Dolasetron—Flushing—Simvastatin—atherosclerosis	0.000854	0.00367	CcSEcCtD
Dolasetron—Flatulence—Lovastatin—atherosclerosis	0.000844	0.00362	CcSEcCtD
Dolasetron—Dysgeusia—Lovastatin—atherosclerosis	0.000839	0.0036	CcSEcCtD
Dolasetron—Oedema peripheral—Niacin—atherosclerosis	0.000833	0.00357	CcSEcCtD
Dolasetron—Confusional state—Rosuvastatin—atherosclerosis	0.000832	0.00357	CcSEcCtD
Dolasetron—Flatulence—Ezetimibe—atherosclerosis	0.000828	0.00355	CcSEcCtD
Dolasetron—Chills—Simvastatin—atherosclerosis	0.000826	0.00354	CcSEcCtD
Dolasetron—Visual impairment—Niacin—atherosclerosis	0.000815	0.0035	CcSEcCtD
Dolasetron—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000808	0.00347	CcSEcCtD
Dolasetron—Tremor—Lovastatin—atherosclerosis	0.000803	0.00344	CcSEcCtD
Dolasetron—Visual impairment—Pravastatin—atherosclerosis	0.000802	0.00344	CcSEcCtD
Dolasetron—Ill-defined disorder—Lovastatin—atherosclerosis	0.000795	0.00341	CcSEcCtD
Dolasetron—Flatulence—Simvastatin—atherosclerosis	0.00079	0.00339	CcSEcCtD
Dolasetron—Tinnitus—Niacin—atherosclerosis	0.000788	0.00338	CcSEcCtD
Dolasetron—Dysgeusia—Simvastatin—atherosclerosis	0.000785	0.00337	CcSEcCtD
Dolasetron—Flushing—Niacin—atherosclerosis	0.000784	0.00337	CcSEcCtD
Dolasetron—Angioedema—Lovastatin—atherosclerosis	0.000783	0.00336	CcSEcCtD
Dolasetron—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00078	0.00335	CcSEcCtD
Dolasetron—Anaemia—Ezetimibe—atherosclerosis	0.000777	0.00333	CcSEcCtD
Dolasetron—Tinnitus—Pravastatin—atherosclerosis	0.000776	0.00333	CcSEcCtD
Dolasetron—Malaise—Lovastatin—atherosclerosis	0.000773	0.00332	CcSEcCtD
Dolasetron—Flushing—Pravastatin—atherosclerosis	0.000772	0.00331	CcSEcCtD
Dolasetron—Vertigo—Lovastatin—atherosclerosis	0.00077	0.0033	CcSEcCtD
Dolasetron—Angioedema—Ezetimibe—atherosclerosis	0.000768	0.0033	CcSEcCtD
Dolasetron—Chills—Niacin—atherosclerosis	0.000758	0.00326	CcSEcCtD
Dolasetron—Malaise—Ezetimibe—atherosclerosis	0.000758	0.00325	CcSEcCtD
Dolasetron—Arrhythmia—Niacin—atherosclerosis	0.000755	0.00324	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000752	0.00323	CcSEcCtD
Dolasetron—Tremor—Simvastatin—atherosclerosis	0.000751	0.00322	CcSEcCtD
Dolasetron—Chills—Pravastatin—atherosclerosis	0.000747	0.0032	CcSEcCtD
Dolasetron—Ill-defined disorder—Simvastatin—atherosclerosis	0.000744	0.00319	CcSEcCtD
Dolasetron—Arrhythmia—Pravastatin—atherosclerosis	0.000743	0.00319	CcSEcCtD
Dolasetron—Palpitations—Ezetimibe—atherosclerosis	0.000743	0.00319	CcSEcCtD
Dolasetron—Paraesthesia—Rosuvastatin—atherosclerosis	0.000741	0.00318	CcSEcCtD
Dolasetron—Anaemia—Simvastatin—atherosclerosis	0.000741	0.00318	CcSEcCtD
Dolasetron—Cough—Ezetimibe—atherosclerosis	0.000733	0.00315	CcSEcCtD
Dolasetron—Angioedema—Simvastatin—atherosclerosis	0.000732	0.00314	CcSEcCtD
Dolasetron—Chest pain—Lovastatin—atherosclerosis	0.000729	0.00313	CcSEcCtD
Dolasetron—Arthralgia—Lovastatin—atherosclerosis	0.000729	0.00313	CcSEcCtD
Dolasetron—Myalgia—Lovastatin—atherosclerosis	0.000729	0.00313	CcSEcCtD
Dolasetron—Anxiety—Lovastatin—atherosclerosis	0.000727	0.00312	CcSEcCtD
Dolasetron—Dyspepsia—Rosuvastatin—atherosclerosis	0.000726	0.00312	CcSEcCtD
Dolasetron—Hypertension—Ezetimibe—atherosclerosis	0.000725	0.00311	CcSEcCtD
Dolasetron—Flatulence—Niacin—atherosclerosis	0.000725	0.00311	CcSEcCtD
Dolasetron—Malaise—Simvastatin—atherosclerosis	0.000723	0.0031	CcSEcCtD
Dolasetron—Discomfort—Lovastatin—atherosclerosis	0.000721	0.00309	CcSEcCtD
Dolasetron—Vertigo—Simvastatin—atherosclerosis	0.00072	0.00309	CcSEcCtD
Dolasetron—Arthralgia—Ezetimibe—atherosclerosis	0.000715	0.00307	CcSEcCtD
Dolasetron—Chest pain—Ezetimibe—atherosclerosis	0.000715	0.00307	CcSEcCtD
Dolasetron—Myalgia—Ezetimibe—atherosclerosis	0.000715	0.00307	CcSEcCtD
Dolasetron—Flatulence—Pravastatin—atherosclerosis	0.000714	0.00306	CcSEcCtD
Dolasetron—Dry mouth—Lovastatin—atherosclerosis	0.000713	0.00306	CcSEcCtD
Dolasetron—Dysgeusia—Pravastatin—atherosclerosis	0.000709	0.00304	CcSEcCtD
Dolasetron—Discomfort—Ezetimibe—atherosclerosis	0.000707	0.00303	CcSEcCtD
Dolasetron—Constipation—Rosuvastatin—atherosclerosis	0.000706	0.00303	CcSEcCtD
Dolasetron—Pain—Rosuvastatin—atherosclerosis	0.000706	0.00303	CcSEcCtD
Dolasetron—Confusional state—Lovastatin—atherosclerosis	0.000705	0.00303	CcSEcCtD
Dolasetron—Dry mouth—Ezetimibe—atherosclerosis	0.0007	0.003	CcSEcCtD
Dolasetron—Anaphylactic shock—Lovastatin—atherosclerosis	0.000699	0.003	CcSEcCtD
Dolasetron—Confusional state—Ezetimibe—atherosclerosis	0.000691	0.00297	CcSEcCtD
Dolasetron—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000686	0.00294	CcSEcCtD
Dolasetron—Thrombocytopenia—Lovastatin—atherosclerosis	0.000685	0.00294	CcSEcCtD
Dolasetron—Arthralgia—Simvastatin—atherosclerosis	0.000682	0.00293	CcSEcCtD
Dolasetron—Chest pain—Simvastatin—atherosclerosis	0.000682	0.00293	CcSEcCtD
Dolasetron—Myalgia—Simvastatin—atherosclerosis	0.000682	0.00293	CcSEcCtD
Dolasetron—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00068	0.00292	CcSEcCtD
Dolasetron—Anxiety—Simvastatin—atherosclerosis	0.00068	0.00292	CcSEcCtD
Dolasetron—Tremor—Pravastatin—atherosclerosis	0.000679	0.00291	CcSEcCtD
Dolasetron—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000675	0.0029	CcSEcCtD
Dolasetron—Discomfort—Simvastatin—atherosclerosis	0.000674	0.00289	CcSEcCtD
Dolasetron—Angioedema—Niacin—atherosclerosis	0.000672	0.00289	CcSEcCtD
Dolasetron—Ill-defined disorder—Pravastatin—atherosclerosis	0.000672	0.00289	CcSEcCtD
Dolasetron—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000671	0.00288	CcSEcCtD
Dolasetron—Anaemia—Pravastatin—atherosclerosis	0.00067	0.00287	CcSEcCtD
Dolasetron—Anorexia—Lovastatin—atherosclerosis	0.000666	0.00286	CcSEcCtD
Dolasetron—Angioedema—Pravastatin—atherosclerosis	0.000662	0.00284	CcSEcCtD
Dolasetron—Vertigo—Niacin—atherosclerosis	0.000661	0.00284	CcSEcCtD
Dolasetron—Syncope—Niacin—atherosclerosis	0.00066	0.00283	CcSEcCtD
Dolasetron—Confusional state—Simvastatin—atherosclerosis	0.000659	0.00283	CcSEcCtD
Dolasetron—Urticaria—Rosuvastatin—atherosclerosis	0.000655	0.00281	CcSEcCtD
Dolasetron—Anaphylactic shock—Simvastatin—atherosclerosis	0.000654	0.00281	CcSEcCtD
Dolasetron—Oedema—Simvastatin—atherosclerosis	0.000654	0.00281	CcSEcCtD
Dolasetron—Malaise—Pravastatin—atherosclerosis	0.000653	0.0028	CcSEcCtD
Dolasetron—Abdominal pain—Rosuvastatin—atherosclerosis	0.000652	0.0028	CcSEcCtD
Dolasetron—Vertigo—Pravastatin—atherosclerosis	0.000651	0.00279	CcSEcCtD
Dolasetron—Palpitations—Niacin—atherosclerosis	0.00065	0.00279	CcSEcCtD
Dolasetron—Loss of consciousness—Niacin—atherosclerosis	0.000647	0.00278	CcSEcCtD
Dolasetron—Cough—Niacin—atherosclerosis	0.000642	0.00276	CcSEcCtD
Dolasetron—Thrombocytopenia—Simvastatin—atherosclerosis	0.00064	0.00275	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000637	0.00273	CcSEcCtD
Dolasetron—Cough—Pravastatin—atherosclerosis	0.000632	0.00271	CcSEcCtD
Dolasetron—Paraesthesia—Lovastatin—atherosclerosis	0.000628	0.00269	CcSEcCtD
Dolasetron—Arthralgia—Niacin—atherosclerosis	0.000626	0.00269	CcSEcCtD
Dolasetron—Myalgia—Niacin—atherosclerosis	0.000626	0.00269	CcSEcCtD
Dolasetron—Hypertension—Pravastatin—atherosclerosis	0.000625	0.00268	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000625	0.00268	CcSEcCtD
Dolasetron—Anorexia—Simvastatin—atherosclerosis	0.000623	0.00268	CcSEcCtD
Dolasetron—Dyspnoea—Lovastatin—atherosclerosis	0.000623	0.00268	CcSEcCtD
Dolasetron—Arthralgia—Pravastatin—atherosclerosis	0.000617	0.00265	CcSEcCtD
Dolasetron—Chest pain—Pravastatin—atherosclerosis	0.000617	0.00265	CcSEcCtD
Dolasetron—Myalgia—Pravastatin—atherosclerosis	0.000617	0.00265	CcSEcCtD
Dolasetron—Paraesthesia—Ezetimibe—atherosclerosis	0.000616	0.00264	CcSEcCtD
Dolasetron—Dyspepsia—Lovastatin—atherosclerosis	0.000615	0.00264	CcSEcCtD
Dolasetron—Anxiety—Pravastatin—atherosclerosis	0.000615	0.00264	CcSEcCtD
Dolasetron—Dry mouth—Niacin—atherosclerosis	0.000613	0.00263	CcSEcCtD
Dolasetron—Dyspnoea—Ezetimibe—atherosclerosis	0.000611	0.00262	CcSEcCtD
Dolasetron—Discomfort—Pravastatin—atherosclerosis	0.000609	0.00262	CcSEcCtD
Dolasetron—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000608	0.00261	CcSEcCtD
Dolasetron—Decreased appetite—Lovastatin—atherosclerosis	0.000608	0.00261	CcSEcCtD
Dolasetron—Dyspepsia—Ezetimibe—atherosclerosis	0.000604	0.00259	CcSEcCtD
Dolasetron—Fatigue—Lovastatin—atherosclerosis	0.000603	0.00259	CcSEcCtD
Dolasetron—Anaphylactic shock—Niacin—atherosclerosis	0.000601	0.00258	CcSEcCtD
Dolasetron—Oedema—Niacin—atherosclerosis	0.000601	0.00258	CcSEcCtD
Dolasetron—Pain—Lovastatin—atherosclerosis	0.000598	0.00257	CcSEcCtD
Dolasetron—Constipation—Lovastatin—atherosclerosis	0.000598	0.00257	CcSEcCtD
Dolasetron—Confusional state—Pravastatin—atherosclerosis	0.000596	0.00256	CcSEcCtD
Dolasetron—Decreased appetite—Ezetimibe—atherosclerosis	0.000596	0.00256	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000596	0.00256	CcSEcCtD
Dolasetron—Asthenia—Rosuvastatin—atherosclerosis	0.000592	0.00254	CcSEcCtD
Dolasetron—Oedema—Pravastatin—atherosclerosis	0.000591	0.00254	CcSEcCtD
Dolasetron—Anaphylactic shock—Pravastatin—atherosclerosis	0.000591	0.00254	CcSEcCtD
Dolasetron—Fatigue—Ezetimibe—atherosclerosis	0.000591	0.00254	CcSEcCtD
Dolasetron—Shock—Niacin—atherosclerosis	0.000591	0.00254	CcSEcCtD
Dolasetron—Paraesthesia—Simvastatin—atherosclerosis	0.000587	0.00252	CcSEcCtD
Dolasetron—Pain—Ezetimibe—atherosclerosis	0.000586	0.00252	CcSEcCtD
Dolasetron—Constipation—Ezetimibe—atherosclerosis	0.000586	0.00252	CcSEcCtD
Dolasetron—Tachycardia—Niacin—atherosclerosis	0.000586	0.00252	CcSEcCtD
Dolasetron—Pruritus—Rosuvastatin—atherosclerosis	0.000584	0.00251	CcSEcCtD
Dolasetron—Dyspnoea—Simvastatin—atherosclerosis	0.000583	0.0025	CcSEcCtD
Dolasetron—Hyperhidrosis—Niacin—atherosclerosis	0.000581	0.00249	CcSEcCtD
Dolasetron—Thrombocytopenia—Pravastatin—atherosclerosis	0.000579	0.00248	CcSEcCtD
Dolasetron—Feeling abnormal—Lovastatin—atherosclerosis	0.000576	0.00247	CcSEcCtD
Dolasetron—Dyspepsia—Simvastatin—atherosclerosis	0.000576	0.00247	CcSEcCtD
Dolasetron—Anorexia—Niacin—atherosclerosis	0.000572	0.00246	CcSEcCtD
Dolasetron—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000572	0.00245	CcSEcCtD
Dolasetron—Hyperhidrosis—Pravastatin—atherosclerosis	0.000572	0.00245	CcSEcCtD
Dolasetron—Decreased appetite—Simvastatin—atherosclerosis	0.000569	0.00244	CcSEcCtD
Dolasetron—Feeling abnormal—Ezetimibe—atherosclerosis	0.000565	0.00243	CcSEcCtD
Dolasetron—Diarrhoea—Rosuvastatin—atherosclerosis	0.000565	0.00242	CcSEcCtD
Dolasetron—Fatigue—Simvastatin—atherosclerosis	0.000564	0.00242	CcSEcCtD
Dolasetron—Anorexia—Pravastatin—atherosclerosis	0.000564	0.00242	CcSEcCtD
Dolasetron—Hypotension—Niacin—atherosclerosis	0.000561	0.00241	CcSEcCtD
Dolasetron—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000561	0.00241	CcSEcCtD
Dolasetron—Pain—Simvastatin—atherosclerosis	0.000559	0.0024	CcSEcCtD
Dolasetron—Constipation—Simvastatin—atherosclerosis	0.000559	0.0024	CcSEcCtD
Dolasetron—Urticaria—Lovastatin—atherosclerosis	0.000555	0.00238	CcSEcCtD
Dolasetron—Body temperature increased—Lovastatin—atherosclerosis	0.000553	0.00237	CcSEcCtD
Dolasetron—Abdominal pain—Lovastatin—atherosclerosis	0.000553	0.00237	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000547	0.00235	CcSEcCtD
Dolasetron—Dizziness—Rosuvastatin—atherosclerosis	0.000546	0.00234	CcSEcCtD
Dolasetron—Urticaria—Ezetimibe—atherosclerosis	0.000545	0.00234	CcSEcCtD
Dolasetron—Body temperature increased—Ezetimibe—atherosclerosis	0.000542	0.00233	CcSEcCtD
Dolasetron—Abdominal pain—Ezetimibe—atherosclerosis	0.000542	0.00233	CcSEcCtD
Dolasetron—Paraesthesia—Niacin—atherosclerosis	0.000539	0.00231	CcSEcCtD
Dolasetron—Feeling abnormal—Simvastatin—atherosclerosis	0.000539	0.00231	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000539	0.00231	CcSEcCtD
Dolasetron—Dyspnoea—Niacin—atherosclerosis	0.000535	0.0023	CcSEcCtD
Dolasetron—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000535	0.0023	CcSEcCtD
Dolasetron—Somnolence—Niacin—atherosclerosis	0.000534	0.00229	CcSEcCtD
Dolasetron—Paraesthesia—Pravastatin—atherosclerosis	0.000531	0.00228	CcSEcCtD
Dolasetron—Dyspepsia—Niacin—atherosclerosis	0.000529	0.00227	CcSEcCtD
Dolasetron—Dyspnoea—Pravastatin—atherosclerosis	0.000527	0.00226	CcSEcCtD
Dolasetron—Decreased appetite—Niacin—atherosclerosis	0.000522	0.00224	CcSEcCtD
Dolasetron—Dyspepsia—Pravastatin—atherosclerosis	0.00052	0.00223	CcSEcCtD
Dolasetron—Rash—Rosuvastatin—atherosclerosis	0.00052	0.00223	CcSEcCtD
Dolasetron—Dermatitis—Rosuvastatin—atherosclerosis	0.00052	0.00223	CcSEcCtD
Dolasetron—Urticaria—Simvastatin—atherosclerosis	0.00052	0.00223	CcSEcCtD
Dolasetron—Abdominal pain—Simvastatin—atherosclerosis	0.000517	0.00222	CcSEcCtD
Dolasetron—Body temperature increased—Simvastatin—atherosclerosis	0.000517	0.00222	CcSEcCtD
Dolasetron—Headache—Rosuvastatin—atherosclerosis	0.000517	0.00222	CcSEcCtD
Dolasetron—Hypersensitivity—Lovastatin—atherosclerosis	0.000515	0.00221	CcSEcCtD
Dolasetron—Decreased appetite—Pravastatin—atherosclerosis	0.000514	0.00221	CcSEcCtD
Dolasetron—Pain—Niacin—atherosclerosis	0.000514	0.0022	CcSEcCtD
Dolasetron—Fatigue—Pravastatin—atherosclerosis	0.00051	0.00219	CcSEcCtD
Dolasetron—Pain—Pravastatin—atherosclerosis	0.000506	0.00217	CcSEcCtD
Dolasetron—Constipation—Pravastatin—atherosclerosis	0.000506	0.00217	CcSEcCtD
Dolasetron—Hypersensitivity—Ezetimibe—atherosclerosis	0.000505	0.00217	CcSEcCtD
Dolasetron—Asthenia—Lovastatin—atherosclerosis	0.000502	0.00215	CcSEcCtD
Dolasetron—Pruritus—Lovastatin—atherosclerosis	0.000495	0.00212	CcSEcCtD
Dolasetron—Asthenia—Ezetimibe—atherosclerosis	0.000492	0.00211	CcSEcCtD
Dolasetron—Gastrointestinal pain—Niacin—atherosclerosis	0.000491	0.00211	CcSEcCtD
Dolasetron—Feeling abnormal—Pravastatin—atherosclerosis	0.000487	0.00209	CcSEcCtD
Dolasetron—Pruritus—Ezetimibe—atherosclerosis	0.000485	0.00208	CcSEcCtD
Dolasetron—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000483	0.00208	CcSEcCtD
Dolasetron—Hypersensitivity—Simvastatin—atherosclerosis	0.000482	0.00207	CcSEcCtD
Dolasetron—Diarrhoea—Lovastatin—atherosclerosis	0.000478	0.00205	CcSEcCtD
Dolasetron—Urticaria—Niacin—atherosclerosis	0.000477	0.00205	CcSEcCtD
Dolasetron—Body temperature increased—Niacin—atherosclerosis	0.000475	0.00204	CcSEcCtD
Dolasetron—Abdominal pain—Niacin—atherosclerosis	0.000475	0.00204	CcSEcCtD
Dolasetron—Urticaria—Pravastatin—atherosclerosis	0.00047	0.00202	CcSEcCtD
Dolasetron—Asthenia—Simvastatin—atherosclerosis	0.000469	0.00201	CcSEcCtD
Dolasetron—Diarrhoea—Ezetimibe—atherosclerosis	0.000469	0.00201	CcSEcCtD
Dolasetron—Abdominal pain—Pravastatin—atherosclerosis	0.000467	0.00201	CcSEcCtD
Dolasetron—Body temperature increased—Pravastatin—atherosclerosis	0.000467	0.00201	CcSEcCtD
Dolasetron—Pruritus—Simvastatin—atherosclerosis	0.000463	0.00199	CcSEcCtD
Dolasetron—Dizziness—Lovastatin—atherosclerosis	0.000462	0.00198	CcSEcCtD
Dolasetron—Dizziness—Ezetimibe—atherosclerosis	0.000454	0.00195	CcSEcCtD
Dolasetron—Diarrhoea—Simvastatin—atherosclerosis	0.000447	0.00192	CcSEcCtD
Dolasetron—Hypersensitivity—Niacin—atherosclerosis	0.000442	0.0019	CcSEcCtD
Dolasetron—Rash—Lovastatin—atherosclerosis	0.000441	0.00189	CcSEcCtD
Dolasetron—Dermatitis—Lovastatin—atherosclerosis	0.00044	0.00189	CcSEcCtD
Dolasetron—Headache—Lovastatin—atherosclerosis	0.000438	0.00188	CcSEcCtD
Dolasetron—Hypersensitivity—Pravastatin—atherosclerosis	0.000436	0.00187	CcSEcCtD
Dolasetron—Dizziness—Simvastatin—atherosclerosis	0.000432	0.00186	CcSEcCtD
Dolasetron—Rash—Ezetimibe—atherosclerosis	0.000432	0.00186	CcSEcCtD
Dolasetron—Dermatitis—Ezetimibe—atherosclerosis	0.000432	0.00185	CcSEcCtD
Dolasetron—Asthenia—Niacin—atherosclerosis	0.000431	0.00185	CcSEcCtD
Dolasetron—Headache—Ezetimibe—atherosclerosis	0.00043	0.00184	CcSEcCtD
Dolasetron—Pruritus—Niacin—atherosclerosis	0.000425	0.00182	CcSEcCtD
Dolasetron—Asthenia—Pravastatin—atherosclerosis	0.000424	0.00182	CcSEcCtD
Dolasetron—Pruritus—Pravastatin—atherosclerosis	0.000418	0.0018	CcSEcCtD
Dolasetron—Rash—Simvastatin—atherosclerosis	0.000412	0.00177	CcSEcCtD
Dolasetron—Dermatitis—Simvastatin—atherosclerosis	0.000412	0.00177	CcSEcCtD
Dolasetron—Diarrhoea—Niacin—atherosclerosis	0.000411	0.00176	CcSEcCtD
Dolasetron—Headache—Simvastatin—atherosclerosis	0.00041	0.00176	CcSEcCtD
Dolasetron—Diarrhoea—Pravastatin—atherosclerosis	0.000405	0.00174	CcSEcCtD
Dolasetron—Dizziness—Niacin—atherosclerosis	0.000397	0.0017	CcSEcCtD
Dolasetron—Dizziness—Pravastatin—atherosclerosis	0.000391	0.00168	CcSEcCtD
Dolasetron—Rash—Niacin—atherosclerosis	0.000379	0.00163	CcSEcCtD
Dolasetron—Dermatitis—Niacin—atherosclerosis	0.000378	0.00162	CcSEcCtD
Dolasetron—Headache—Niacin—atherosclerosis	0.000376	0.00161	CcSEcCtD
Dolasetron—Rash—Pravastatin—atherosclerosis	0.000373	0.0016	CcSEcCtD
Dolasetron—Dermatitis—Pravastatin—atherosclerosis	0.000372	0.0016	CcSEcCtD
Dolasetron—Headache—Pravastatin—atherosclerosis	0.00037	0.00159	CcSEcCtD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	4.27e-05	0.012	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	4.24e-05	0.0119	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	4.22e-05	0.0119	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ABCG8—atherosclerosis	4.21e-05	0.0118	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	4.18e-05	0.0118	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	3.95e-05	0.0111	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	3.92e-05	0.011	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	3.9e-05	0.011	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	3.86e-05	0.0109	CbGpPWpGaD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	3.81e-05	0.0107	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—IL10—atherosclerosis	3.69e-05	0.0104	CbGpPWpGaD
Dolasetron—CYP2C9—Arachidonic acid metabolism—ALOX5—atherosclerosis	3.65e-05	0.0103	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	3.46e-05	0.00974	CbGpPWpGaD
Dolasetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	3.45e-05	0.00969	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	3.43e-05	0.00966	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ABCG1—atherosclerosis	3.33e-05	0.00936	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	3.2e-05	0.00901	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—EDN1—atherosclerosis	3.19e-05	0.00898	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	3.17e-05	0.00893	CbGpPWpGaD
Dolasetron—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	3.02e-05	0.0085	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	3.02e-05	0.00849	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	2.79e-05	0.00786	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	2.76e-05	0.00776	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—TRPV1—atherosclerosis	2.71e-05	0.00763	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ABCG5—atherosclerosis	2.61e-05	0.00735	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—APOE—atherosclerosis	2.6e-05	0.0073	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	2.58e-05	0.00726	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	2.55e-05	0.00717	CbGpPWpGaD
Dolasetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	2.39e-05	0.00672	CbGpPWpGaD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	2.27e-05	0.00639	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	2.27e-05	0.00637	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	2.09e-05	0.00589	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	2.02e-05	0.00567	CbGpPWpGaD
Dolasetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	1.97e-05	0.00555	CbGpPWpGaD
Dolasetron—CYP2C9—Arachidonic acid metabolism—GPX1—atherosclerosis	1.94e-05	0.00545	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—IL1B—atherosclerosis	1.93e-05	0.00544	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—CETP—atherosclerosis	1.93e-05	0.00544	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP7A1—atherosclerosis	1.84e-05	0.00518	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP7A1—atherosclerosis	1.82e-05	0.00513	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP7A1—atherosclerosis	1.81e-05	0.00511	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	1.8e-05	0.00508	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP7A1—atherosclerosis	1.8e-05	0.00506	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—PLAT—atherosclerosis	1.7e-05	0.00479	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP27A1—atherosclerosis	1.7e-05	0.00478	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP27A1—atherosclerosis	1.69e-05	0.00474	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP27A1—atherosclerosis	1.68e-05	0.00472	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP27A1—atherosclerosis	1.66e-05	0.00468	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	1.64e-05	0.00461	CbGpPWpGaD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	1.58e-05	0.00443	CbGpPWpGaD
Dolasetron—CYP2D6—Melatonin metabolism and effects—NFKB1—atherosclerosis	1.54e-05	0.00434	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—PLG—atherosclerosis	1.45e-05	0.00407	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—TNF—atherosclerosis	1.4e-05	0.00395	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.34e-05	0.00376	CbGpPWpGaD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	1.3e-05	0.00366	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—APOB—atherosclerosis	1.28e-05	0.0036	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	1.2e-05	0.00338	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	1.2e-05	0.00337	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	1.19e-05	0.00334	CbGpPWpGaD
Dolasetron—CYP2C9—Arachidonic acid metabolism—PTGS2—atherosclerosis	1.14e-05	0.00321	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—IL6—atherosclerosis	1.13e-05	0.00319	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	1.13e-05	0.00317	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	1.11e-05	0.00313	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	1.1e-05	0.00309	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.08e-05	0.00304	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.01e-05	0.00285	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	9.78e-06	0.00275	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	9.78e-06	0.00275	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ALB—atherosclerosis	8.03e-06	0.00226	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	7.73e-06	0.00217	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	7.6e-06	0.00214	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	7.53e-06	0.00212	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	7.49e-06	0.00211	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	7.43e-06	0.00209	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	7.27e-06	0.00204	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	7.27e-06	0.00204	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	7.13e-06	0.00201	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	7.01e-06	0.00197	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	6.48e-06	0.00182	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	6.14e-06	0.00173	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	6.14e-06	0.00173	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	6.14e-06	0.00173	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	6.14e-06	0.00173	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	6.06e-06	0.00171	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	5.86e-06	0.00165	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	5.61e-06	0.00158	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	5.4e-06	0.00152	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	5.39e-06	0.00152	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	5.34e-06	0.0015	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	5.22e-06	0.00147	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLTP—atherosclerosis	5.06e-06	0.00142	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLTP—atherosclerosis	5.02e-06	0.00141	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	4.97e-06	0.0014	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	4.9e-06	0.00138	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	4.65e-06	0.00131	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	4.62e-06	0.0013	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	4.6e-06	0.00129	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	4.49e-06	0.00126	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCG8—atherosclerosis	4.39e-06	0.00124	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LTA4H—atherosclerosis	4.39e-06	0.00124	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LTA4H—atherosclerosis	4.35e-06	0.00122	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCG8—atherosclerosis	4.35e-06	0.00122	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.3e-06	0.00121	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	4.06e-06	0.00114	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.62e-06	0.00102	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	3.52e-06	0.000991	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCG1—atherosclerosis	3.47e-06	0.000976	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCG1—atherosclerosis	3.44e-06	0.000968	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLTP—atherosclerosis	3.31e-06	0.000931	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—FABP4—atherosclerosis	3.26e-06	0.000918	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LCAT—atherosclerosis	3.26e-06	0.000918	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LCAT—atherosclerosis	3.24e-06	0.00091	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—FABP4—atherosclerosis	3.24e-06	0.00091	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOA4—atherosclerosis	3.2e-06	0.000901	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOA4—atherosclerosis	3.18e-06	0.000893	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP7A1—atherosclerosis	3.15e-06	0.000885	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP7A1—atherosclerosis	3.12e-06	0.000878	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.97e-06	0.000836	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.91e-06	0.000818	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2.88e-06	0.000811	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.87e-06	0.000808	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.87e-06	0.000808	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.84e-06	0.000799	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.77e-06	0.000779	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.76e-06	0.000776	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOA2—atherosclerosis	2.76e-06	0.000776	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.76e-06	0.000776	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.76e-06	0.000776	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOA2—atherosclerosis	2.73e-06	0.000769	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	2.73e-06	0.000769	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALOX15—atherosclerosis	2.73e-06	0.000769	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	2.73e-06	0.000769	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.72e-06	0.000766	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCG5—atherosclerosis	2.7e-06	0.00076	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.7e-06	0.000759	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LPA—atherosclerosis	2.63e-06	0.00074	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LPA—atherosclerosis	2.61e-06	0.000734	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—BGN—atherosclerosis	2.55e-06	0.000717	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—BGN—atherosclerosis	2.53e-06	0.00071	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOA5—atherosclerosis	2.52e-06	0.000709	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.51e-06	0.000705	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOA5—atherosclerosis	2.5e-06	0.000703	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.43e-06	0.000683	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	2.43e-06	0.000683	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	2.41e-06	0.000677	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.38e-06	0.000669	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.36e-06	0.000663	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.35e-06	0.000662	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALOX5—atherosclerosis	2.34e-06	0.00066	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALOX5—atherosclerosis	2.32e-06	0.000654	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.27e-06	0.000638	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.15e-06	0.000604	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LCAT—atherosclerosis	2.13e-06	0.0006	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—FABP4—atherosclerosis	2.13e-06	0.0006	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NAMPT—atherosclerosis	2.1e-06	0.000592	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOA4—atherosclerosis	2.09e-06	0.000589	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LIPC—atherosclerosis	2.09e-06	0.000588	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NAMPT—atherosclerosis	2.08e-06	0.000586	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOC3—atherosclerosis	2.08e-06	0.000584	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.07e-06	0.000583	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LIPC—atherosclerosis	2.07e-06	0.000583	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LDLR—atherosclerosis	2.06e-06	0.000581	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOC3—atherosclerosis	2.06e-06	0.000579	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP7A1—atherosclerosis	2.06e-06	0.000579	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LDLR—atherosclerosis	2.05e-06	0.000576	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CETP—atherosclerosis	2.02e-06	0.000567	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CETP—atherosclerosis	2e-06	0.000562	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.93e-06	0.000543	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.91e-06	0.000538	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.9e-06	0.000535	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.86e-06	0.000524	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.82e-06	0.000513	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.81e-06	0.000508	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.8e-06	0.000507	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.8e-06	0.000507	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOA2—atherosclerosis	1.8e-06	0.000507	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.8e-06	0.000507	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.78e-06	0.000501	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LPA—atherosclerosis	1.72e-06	0.000484	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—BGN—atherosclerosis	1.67e-06	0.000469	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOA5—atherosclerosis	1.65e-06	0.000464	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.63e-06	0.000459	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.63e-06	0.000457	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.61e-06	0.000453	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.59e-06	0.000446	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.53e-06	0.000431	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.39e-06	0.000392	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.38e-06	0.000389	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.38e-06	0.000387	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LIPC—atherosclerosis	1.37e-06	0.000384	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOC3—atherosclerosis	1.36e-06	0.000382	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LDLR—atherosclerosis	1.35e-06	0.00038	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOB—atherosclerosis	1.34e-06	0.000376	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOB—atherosclerosis	1.32e-06	0.000372	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CETP—atherosclerosis	1.32e-06	0.000371	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.3e-06	0.000365	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.29e-06	0.000362	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LPL—atherosclerosis	1.28e-06	0.000359	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LPL—atherosclerosis	1.26e-06	0.000356	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.26e-06	0.000355	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GPX1—atherosclerosis	1.24e-06	0.00035	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GPX1—atherosclerosis	1.23e-06	0.000347	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CD36—atherosclerosis	1.21e-06	0.000341	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CD36—atherosclerosis	1.2e-06	0.000338	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.19e-06	0.000335	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.15e-06	0.000323	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.14e-06	0.00032	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPARA—atherosclerosis	1.13e-06	0.000317	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPARA—atherosclerosis	1.12e-06	0.000314	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AGT—atherosclerosis	1.09e-06	0.000307	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AGT—atherosclerosis	1.08e-06	0.000304	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOE—atherosclerosis	1.07e-06	0.000301	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.06e-06	0.000299	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOE—atherosclerosis	1.06e-06	0.000298	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CAV1—atherosclerosis	1.06e-06	0.000298	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOA1—atherosclerosis	1.06e-06	0.000297	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CAV1—atherosclerosis	1.05e-06	0.000295	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOA1—atherosclerosis	1.05e-06	0.000295	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3CG—atherosclerosis	9.65e-07	0.000271	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3CG—atherosclerosis	9.56e-07	0.000269	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPARG—atherosclerosis	9.31e-07	0.000262	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPARG—atherosclerosis	9.23e-07	0.00026	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—INS—atherosclerosis	9.13e-07	0.000257	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HMOX1—atherosclerosis	9.12e-07	0.000256	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—INS—atherosclerosis	9.05e-07	0.000255	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOB—atherosclerosis	8.73e-07	0.000246	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTM1—atherosclerosis	8.5e-07	0.000239	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALB—atherosclerosis	8.37e-07	0.000236	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LPL—atherosclerosis	8.34e-07	0.000235	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALB—atherosclerosis	8.3e-07	0.000233	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GPX1—atherosclerosis	8.14e-07	0.000229	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NOS3—atherosclerosis	8.01e-07	0.000225	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NOS3—atherosclerosis	7.94e-07	0.000223	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CD36—atherosclerosis	7.92e-07	0.000223	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MTHFR—atherosclerosis	7.51e-07	0.000211	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPARA—atherosclerosis	7.37e-07	0.000207	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PTGS2—atherosclerosis	7.33e-07	0.000206	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PTGS2—atherosclerosis	7.26e-07	0.000204	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AGT—atherosclerosis	7.13e-07	0.000201	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOE—atherosclerosis	6.99e-07	0.000197	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CAV1—atherosclerosis	6.93e-07	0.000195	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOA1—atherosclerosis	6.91e-07	0.000194	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3CG—atherosclerosis	6.31e-07	0.000177	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPARG—atherosclerosis	6.09e-07	0.000171	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—INS—atherosclerosis	5.97e-07	0.000168	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALB—atherosclerosis	5.47e-07	0.000154	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NOS3—atherosclerosis	5.24e-07	0.000147	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.79e-07	0.000135	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKT1—atherosclerosis	3.68e-07	0.000104	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKT1—atherosclerosis	3.65e-07	0.000103	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKT1—atherosclerosis	2.41e-07	6.77e-05	CbGpPWpGaD
